Serum fragmented cytokeratin 18 levels reflect the histologic activity score of nonalcoholic fatty liver disease more accurately than serum alanine aminotransferase levels
- PMID: 20104187
- DOI: 10.1097/MCG.0b013e3181bdefe2
Serum fragmented cytokeratin 18 levels reflect the histologic activity score of nonalcoholic fatty liver disease more accurately than serum alanine aminotransferase levels
Abstract
Background and goals: Reliable noninvasive biomarkers to assess the histologic activity of nonalcoholic fatty liver disease (NAFLD) have not been established. As the frequency of Mallory bodies is known to be closely associated with the disease severity, we hypothesized that serum levels of Mallory body-related proteins were correlated with NAFLD histologic activity and evaluated this possibility.
Study: Serum levels of total and fragmented cytokeratin (CK) 18, heat shock protein (Hsp) 70, Hsp90alpha, ubiquitin+1, and p38alpha at the time of liver biopsy were measured in 118 NAFLD patients and their association with histologic findings and NAFLD histologic activity score (NAS) was investigated.
Results: Serum levels of both forms of CK18 and Hsp90alpha were markedly higher in patients having nonalcoholic steatohepatitis (NASH) compared with non-NASH ones. Both forms of CK18 significantly correlated with degree of steatosis, lobular inflammation, and ballooning, and showed stronger positive correlations with NAS than serum aspartate and alanine aminotransferase (AST and ALT). Multiple regression analysis further revealed that fragmented CK18 and AST were effective predictors of NAS, with the former being the more definitive of the two (P<0.001 vs. 0.005). In 20 NAFLD patients who received a follow-up biopsy, changes in fragmented CK18 levels, but not AST or ALT levels, closely paralleled those in NAS.
Conclusions: These results establish the usefulness of fragmented CK18 measurement for assessing and monitoring the histologic activity of NAFLD.
Similar articles
-
[Clinical and histological features of non-alcoholic fatty liver disease].Zhonghua Gan Zang Bing Za Zhi. 2009 Nov;17(11):812-6. Zhonghua Gan Zang Bing Za Zhi. 2009. PMID: 19958638 Chinese.
-
Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.Eur J Gastroenterol Hepatol. 2008 May;20(5):399-403. doi: 10.1097/MEG.0b013e3282f448af. Eur J Gastroenterol Hepatol. 2008. PMID: 18403941
-
Apoptosis markers in liver biopsy of nonalcoholic steatohepatitis in pediatric patients.Hum Pathol. 2008 Dec;39(12):1816-22. doi: 10.1016/j.humpath.2008.04.022. Epub 2008 Aug 20. Hum Pathol. 2008. PMID: 18715620
-
[Role of liver biopsy in the diagnosis of NASH].Nihon Rinsho. 2006 Jun;64(6):1119-25. Nihon Rinsho. 2006. PMID: 16768119 Review. Japanese.
-
[Cytokeratin 18 as an indicator of the activity of liver disease].Pol Merkur Lekarski. 2011 Dec;31(186):331-4. Pol Merkur Lekarski. 2011. PMID: 22239000 Review. Polish.
Cited by
-
The Wide and Complex Field of NAFLD Biomarker Research: Trends.ISRN Hepatol. 2014 Apr 28;2014:846923. doi: 10.1155/2014/846923. eCollection 2014. ISRN Hepatol. 2014. PMID: 27335843 Free PMC article. Review.
-
Proteomic analysis of liver tissue from dogs with chronic hepatitis.PLoS One. 2018 Nov 30;13(11):e0208394. doi: 10.1371/journal.pone.0208394. eCollection 2018. PLoS One. 2018. PMID: 30500850 Free PMC article.
-
Relationship between changes in serum levels of keratin 18 and changes in liver histology in children and adults with nonalcoholic fatty liver disease.Clin Gastroenterol Hepatol. 2014 Dec;12(12):2121-30.e1-2. doi: 10.1016/j.cgh.2014.05.010. Epub 2014 May 17. Clin Gastroenterol Hepatol. 2014. PMID: 24846279 Free PMC article.
-
Serum cell death biomarkers for prediction of liver fibrosis and poor prognosis in primary biliary cirrhosis.PLoS One. 2015 Jun 25;10(6):e0131658. doi: 10.1371/journal.pone.0131658. eCollection 2015. PLoS One. 2015. PMID: 26110613 Free PMC article.
-
A Nine-Strain Bacterial Consortium Improves Portal Hypertension and Insulin Signaling and Delays NAFLD Progression In Vivo.Biomedicines. 2022 May 20;10(5):1191. doi: 10.3390/biomedicines10051191. Biomedicines. 2022. PMID: 35625927 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials